Bledsoe calls the decision to have the LINX procedure "life changing," and has been removed from some of her pre-diagnosis medications as a result.
"LINX was designed specifically for this group of patients whose symptoms are not controlled adequately by medication and who do not have big hiatal hernias, bad esophagitis or other things we see with more advanced disease," Bell says of the device manufactured by Torax® Medical, Inc.
The LINX System is currently the only available device for the treatment of GERD approved by the FDA through its rigorous PMA process.
According to Bell, in a clinical trial of 100 patients, 92% achieved freedom from daily dependence on PPIs, 90% experienced a reduction in total acid exposure time, 93% achieved significant symptom improvement and the percentage of patients reporting moderate to severe regurgitation was reduced from 57% to 1% after the LINX procedure.CONTACT: Betsy Donnelly PH: 913.236.7757 E: Betsy@TrailheadMarketingTeam.com This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com. SOURCE Swedish Medical Center